Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy-Reference-Cited by-同舟云学术

Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy

Published:2005-08-15 Issue:9 Volume:35 Page:536-542
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:

Author:

Fulcher G. R.,Gilbert R. E.,Yue D. K.

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1445-5994.2005.00902.x/fullpdf

Reference9 articles.

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus;The Diabetes Control and Complications Trial Research Group.;N Engl J Med,1993;

2. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH, and ultralente human insulin and continuous subcutaneous infusion of lispro;Lepore;Diabetes,2000;

3. Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart;Heinemann;Diabetes Care,1998;

4. Insulin pharmacokinetics;Binder;Diabetes Care,1984;

5. Efficacy and safety of glargine in subjects with type 1 diabetes: a 28-week randomized, NPH-controlled trial;Ratner;Diabetes,1999;

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin Glargine in Type 1 Diabetes Mellitus: A Review of Clinical Trials and Real-world Evidence Across Two Decades;Current Diabetes Reviews;2024-01

2. Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach;Journal of Mind and Medical Sciences;2023-10-31

3. Comparison of Insulin Analogs and Human Insulins: A Narrative Review;Journal of Diabetes and Endocrine Practice;2023-08-10

4. A Systematic Review Supporting the Endocrine Society Guidelines: Management of Diabetes and High Risk of Hypoglycemia;The Journal of Clinical Endocrinology & Metabolism;2022-12-07

5. Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline;The Journal of Clinical Endocrinology & Metabolism;2022-12-07